Evolving trends in the prevalence of hepatitis C virus antibody positivity among HIV-infected men in a community-based primary care setting.
Evolving trends in the prevalence of hepatitis C virus antibody positivity among HIV-infected men in a community-based primary care setting.
复制标题
DOI:
10.1111/jvh.13354
复制
发表时间:
2020-11
影响因子:
2.5
通讯作者:
Wiberg KJ
中科院分区:
文献类型:
--
作者:
Chen YC;Thio CL;Kamangar F;Cox AL;Wiberg KJ
Hepatitis C virus (HCV) infections in the United States occurred mostly among those born between 1945–1965. However, new infections continue to increase in recent years. To understand the changes in the prevalence and risk factors of HCV infection in different age and risk groups among men living with HIV, we performed a retrospective cross-sectional analyses of 1948 HIV-infected men at a multisite community health center in urban/suburban and rural Maryland from 2003 through 2014. We used multivariate logistic regression to determine factors associated with HCV antibody (anti-HCV) positivity and restricted cubic spline method to model trends in anti-HCV prevalence over time. The overall anti-HCV prevalence was 24.2%. The annual prevalence declined in the full cohort, from 38% in 2003 to 24% in 2014, and among those ≥40 years old. However, the annual prevalence increased initially and then stabilized in the groups of men who were younger (<40 years old) or had injection-drug use and/or sex with men. Among the younger injection-drug users, the prevalence rose from 33% in 2003 to 79% in 2009 and then stabilized. The independent predictors for anti-HCV positivity differed between the men with and without injection-drug use and between those <40 and ≥40 years old. Notably, a high prevalence of anti-HCV was observed among the younger, white injection-drug users residing in rural areas. Thus, the HCV epidemic continued unabated among high-risk individuals in this diverse population of HIV-infected men. The ongoing HCV transmission among young HIV-infected men poses a challenge en route to HCV eradication.
登录
查看更多内容
影响因子:
2.5
作者:
Seaberg EC;Witt MD;Jacobson LP;Detels R;Rinaldo CR;Young S;Phair JP;Thio CL
通讯作者:
Thio CL
影响因子:
11.8
作者:
Moorman, Anne C.;Gordon, Stuart C.;Holmberg, Scott D.
通讯作者:
Holmberg, Scott D.
影响因子:
39.2
作者:
Denniston MM;Jiles RB;Drobeniuc J;Klevens RM;Ward JW;McQuillan GM;Holmberg SD
通讯作者:
Holmberg SD
影响因子:
11.8
作者:
Klevens, R. Monina;Hu, Dale J.;Holmberg, Scott D.
通讯作者:
Holmberg, Scott D.
影响因子:
11.8
作者:
Sherman, KE;Rouster, SD;Rajicic, N
通讯作者:
Rajicic, N